IDL Biotech signs distributor agreement in Ghana
IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF.
January 2021
IDL Biotech signs distributor agreements in Rwanda, South Sudan and Somalia
IDL Biotech continues to expand in Africa. Today, IDL Biotech has signed a distributor agreement with Roi Scientific Ltd covering Rwanda, South Sudan and Somalia. The agreement covers the sale of TUBEX® TF.
Since its launch in Africa, the company has focused on finding the right partners for distribution. IDL Biotech has previously announced that agreements have been signed with distributors in Uganda, Zimbabwe and Kenya. Now the company has also signed a distribution agreement
with Roi Scientific Ltd for distribution in Rwanda, South Sudan and Somalia. The agreement covers the sale of the company’s rapid test TUBEX® TF for typhoid fever.
Read the press release here (Swedish)
IDL Biotech includes additional clinics in its ongoing multicenter study for UBC® Rapid in Sweden.
IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC® Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk.
